YHYurii V. Hutsuliak

Yurii V. Hutsuliak

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Yurii V. Hutsuliak has a total of 18 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Prophylactic Use of V-A ECMO During High-Risk Percutaneous Coronary Interventions: A Single-Center Study

    by Mykhailo Todurov, Borys Todurov, Oleh Zelenchuk, Andrii Maksakov, Yurii Hutsuliak, Stepan Maruniak

    Background. High-risk percutaneous coronary interventions (high-risk PCI) in patients with complex coronary artery disease and reduced left ventricular systolic function are associated with a substantial risk of hemodynamic instability and periprocedural complications. Mechanical circulatory support may improve the safety of these procedures by maintaining adequate systemic perfusion during technically demanding stages of the intervention. Objective: To evaluate the safety and results of prophylactic veno-arterial extracorporeal membrane oxygenation (V-A ECMO) during high-risk PCI in patients with coronary artery disease and to identify factors associated with in-hospital mortality. Methods. A single-center retrospective observational study was conducted, including consecutive patients who underwent elective high-risk PCI with prophylactic V-A ECMO support between 2019 and 2025. The primary endpoint was in-hospital mortality. We used logistic regression to identify predictors of mortality. Results. A total of 43 patients were included in the analysis (mean age 66.1 ± 8.9 years; 74.4% male). The mean left ventricular ejection fraction was 31.9 ± 6.8%, and the mean SYNTAX score was 32.4 ± 6.8. Successful revascularization was achieved in 90.7% of cases, and ECMO weaning at the end of the procedure was possible in 88.4% of patients. In-hospital mortality was 14.0%. Major bleeding occurred in 20.9% of patients, vascular complications in 11.6%, and acute kidney injury in 23.3%. In multivariable analysis, the maximum vasoactive-inotropic score (VIS) was identified as an independent predictor of in-hospital mortality (OR 1.10; 95% CI 1.01–1.21; p = 0.041). Conclusions. Prophylactic V-A ECMO enabled elective high-risk PCI in a highly selected cohort with complex coronary anatomy and impaired left ventricular function. However, the substantial in-hospital mortality and complication rates, together with the retrospective design and absence of a control group, preclude conclusions regarding clinical effectiveness. Prospective controlled studies are required to determine whether prophylactic V-A ECMO improves outcomes compared with unsupported PCI or other mechanical circulatory support strategies.

  • Open Access

    Оцінка якості життя пацієнтів після поєднаного протезування мітрального та аортального клапанів серця залежно від наявності коронарної патології

    by Y. V. Hutsuliak, N. O. Yashchenko, M. B. Todurov, S. R. Maruniak

    The aim – to assess and compare quality of life (QoL) 12 months after combined mitral and aortic valve replacement according to the presence of coronary artery disease (CAD) and the extent of surgical intervention.Materials and methods. A single-center combined prospective and retrospective study (2019–2023) included 157 adult patients who underwent mitral and aortic valve replacement. Patients were allocated to three groups: Group 1 (n = 57) – double-valve replacement + concomitant coronary artery bypass grafting (CABG); Group 2 (n = 50) – double-valve replacement with angiographically confirmed CAD but without concomitant CABG; Group 3 (n = 50) – double-valve replacement without CAD. QoL was assessed at 12 months using the SF-36 questionnaire. Multivariable linear regression was performed to identify independent predictors of reduced physical functioning (PF) and mental health (MH).Results. In-hospital mortality was the highest in the concomitant CABG group (10.5 %) compared with Group 2 (2.0 %) and Group 3 (0 %) (p < 0.05). At 12 months, SF-36 scores demonstrated a graded relationship with surgical extent: the lowest QoL values were observed in Group 1, intermediate in Group 2, and the highest in Group 3 (p < 0.01–0.001). Physical functioning was 42.5 ± 6.4 in Group 1 versus 58.2 ± 5.8 in Group 2 and 64.5 ± 5.2 in Group 3 (p < 0.001). In multivariable analysis, CABG (β = –0.39; p = 0.002), age (β = –0.28; p = 0.010), and NYHA class III–IV (β = –0.33; p = 0.004) were independent predictors of reduced PF, whereas CAD without CABG was not independently associated with PF impairment (p = 0.11). For MH, CABG (β = –0.36; p = 0.004) and NYHA class III–IV (β = –0.29; p = 0.012) were independent predictors.Conclusions. QoL at 12 months after combined mitral and aortic valve replacement is strongly dependent on the extent of surgery. The poorest QoL profile is associated with concomitant CABG, while CAD per se (without CABG) is not an independent determinant of reduced QoL. These findings support tailored postoperative rehabilitation and psychological support for patients undergoing double-valve replacement with CABG.

  • Open Access

    SURGICAL TRICUSPID VALVE REPAIR: RING ANNULOPLASTY AND DE VEGA TECHNIQUE. IMMEDIATE POSTOPERATIVE RESULTS COMPARISON

    by Ruslan F. Mykytenko, Borys M. Todurov, Gavrylo I. Kovtun, Oleg V. Zelenchuk, Natalia O. Yaschenko, Yurii V. Hutsuliak, Alexandros Mourtarakos, Наталія О. Ященко, Юрій В. Гуцуляк, Олександр Муртаракос

    Introduction. Tricuspid regurgitation is associated with progressive right heart failure and increased mortality. The two principal repair techniques are ring annuloplasty (rigid prosthetic ring implantation) and the De Vega suture annuloplasty. Aim. Comparison of short-term results in 32 patients with severe functional tricuspid regurgitation, divided into two equal groups, based on the technique used: Group I (ring annuloplasty) (n=16) and Group II (De Vega suture annuloplasty) (n=16). Materials and methods. Preoperative characteristics, intraoperative data, and postoperative outcomes were collected. Statistical analysis compared group differences in early mortality, complications, and tricuspid regurgitation recurrence. Results were contextualized with contemporary studies and guidelines. Results. Both groups achieved significant reduction of tricuspid regurgitation grade from severe preoperatively to mild or less in most patients at discharge. Residual moderate tricuspid regurgitation was low in both groups (12.5% vs 18.8%, p>0.5). There was no significant difference in early postoperative complications. One in-hospital death occurred in Group I (6.3% mortality) vs. none in Group II. Postoperative echocardiography showed marked reduction in right atrial size and pulmonary artery systolic pressure in both groups (mean pulmonary artery systolic pressure ~44–48 mmHg postoperatively, down from ~60–64 mmHg preoperatively). Left ventricular ejection fraction was mildly improved (from ~56% to 60% in Group I, ~60% to 62% in Group II). Conclusions. Both ring annuloplasty and De Vega suture repair are effective in the early postoperative period, with comparable improvements in hemodynamics and tricuspid regurgitation severity at discharge. However, given the high recurrence rate of suture annuloplasty over time and evidence of improved long-term survival and freedom from tricuspid regurgitation with ring annuloplasty, the use of a prosthetic ring is recommended as the preferred technique for functional tricuspid regurgitation repair whenever feasible.

  • Open Access

    Risk Factors and Complications Structure in Patients After Surgical Treatment of Combined Aortic and Mitral Valve Disease with Concomitant Coronary Artery Disease

    by Yurii V. Hutsuliak, Oleg V. Zelenchuk, Mykhailo B. Todurov, Natalia O. Yashchenko, Mykola H. Melnyk, Borys M. Todurov

    Introduction. Combined aortic and mitral valve lesions on the background of coronary artery disease require complex surgical correction and are associated with high perioperative risk and frequent complications. Local data on such interventions remain limited. Aim. To determine the structure of complications following combined aortic and mitral valve replacement with concomitant coronary artery bypass grafting (AVR+MVR+CABG). Materials and Methods. A retrospective single-center study included 57 patients operated in 2018-2023. Clinical, laboratory, and echocardiographic parameters were analyzed; operative risk was assessed using EuroSCORE II and STS models. Intra- and postoperative parameters were recorded; complications were classified as acute kidney injury (AKI, KDIGO), bleeding (BARC≥3), infectious, neurological, cardiac, pericarditis, rethoracotomy, and in-hospital mortality. Uni- and multivariate logistic regression was used to identify predictors of the composite endpoint (mortality / major complications) with ORs and 95 % CI (p<0.05). Results and discussion. Patients were high-risk: EuroSCORE II Me 7.0 % [4.3-10.9], STS mortality 12.2 % [8.7-17.3], STS mortality/morbidity 61.3 % [49.9-69.0]. In-hospital mortality was 10.5 % (6/57). The main causes of death were acute kidney injury progressing to multiorgan failure (n=2), acute cerebrovascular accident (n=1), pneumonia with septic shock (n=1), mediastinitis with sepsis (n=1), and acute graft thrombosis resulting in myocardial infarction (n=1). Major postoperative complications included: AKI 38.0 % (dialysis-dependent 15.8 %), infectious complications 47.4 % (mediastinitis 7.0 %), neurological disorders 43.9 % (delirium/encephalopathy), stroke 7.0 %, rethoracotomy for bleeding 12.3 %, and pericarditis 10.5 %. Typical hyperlactatemia peaked at 6 hours and normalized within 48 hours. Postoperative valve gradients remained within expected ranges; left ventricular ejection fraction at discharge was Me 50 % [41-56]. Preventive priorities include KDIGO-based AKI prevention, neuroprotection and delirium/stroke prevention strategies, strengthened infection control, blood conservation programs, and refined perioperative risk stratification. Conclusions. The combined valve–coronary cohort demonstrated high surgical risk, with elevated EuroSCORE II and STS indices and hospital mortality of 10.5 %. Functional results were satisfactory: prosthetic valve gradients remained within expected limits, and LVEF at discharge (Me 50 % [41-56]) indicated stable systolic performance. The postoperative course was dominated by an organ-dysfunction–driven complication structure, including renal complications (AKI 38.0 %, dialysis-dependent 15.8 %), infectious events (47.4 %, mediastinitis 7 %), neurological disorders (delirium/encephalopathy 43.9 %, stroke 7 %), and additional cardiac/bleeding complications (re-thoracotomy 12.3 %, pericarditis 10.5 %). The findings support the need for standardized perioperative pathways, emphasizing KDIGO-based renal protection, neuroprotection, infection control, and blood-conservation strategies, with combined EuroSCORE II+STS use for precise risk stratification.


  • Open Access

    Early outcomes of surgical treatment in patients with combined aortic and mitral valve pathology and concomitant coronary artery disease

    by Yu. V. Hutsuliak, O. V. Zelenchuk, N. O. Yashchenko, R. F. Mykytenko, I. M. Kuzmich, N. V. Ponych, M. Lipovac, B. M. Todurov

    The aim – to evaluate the clinical outcomes of surgical treatment in patients with combined aortic and mitral valve disease in the setting of concomitant coronary artery disease (CAD), who underwent simultaneous valve replacement and coronary artery bypass grafting (CABG), with analysis of preoperative, intraoperative, and postoperative parameters. Materials and methods. A retrospective analysis of 35 cases of combined surgical interventions (AVR + MVR + CABG), performed at the Heart Institute of the Ministry of Health of Ukraine between 2019 and 2023, was conducted. The study assessed clinical characteristics, echocardiographic findings, intraoperative data, postoperative course, complications, and mortality rates. Risk stratification was performed using EuroSCORE II and the STS Risk Calculator.Results. In patients with severe multivalvular disease (n = 35), mitral regurgitation (100 %) and concomitant heart failure (94.3 %) were predominant. Postoperative improvement of NYHA class was observed in 74.3 % of cases. Mortality rate was 14.3 %, with infectious (51 %) and neurological (39 %) complications being common. Atrial fibrillation was associated with higher mortality. Postoperative echocardiography showed improved hemodynamics. These findings confirm the effectiveness of combined surgical intervention when careful patient selection is ensured.Conclusions. Simultaneous aortic and mitral valve replacement combined with coronary artery bypass grafting (CABG) represents a clinically justified surgical strategy for patients with combined valvular pathology and coronary artery disease, including those at intermediate and high risk according to the EuroSCORE II and STS scales. Despite acceptable survival rates, the incidence of postoperative complications remains significant, due to acute kidney injury, stroke, infections, ventricular fibrillation, and the need for reinterventions).